Untreated CD30-Positive Hodgkin's Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Untreated CD30-Positive Hodgkin's Lymphoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05481437

A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

This study is a survey in Japan of Brentuximab Vedotin used to treat children or teenagers with Hodgkin lymphoma (HL). The study sponsor will not be involved in…

Japan8 participantsStarted 2022-08-01

Treatment: Brentuximab Vedotin

All recent trials (2 shown)

CompletedNot Applicable

NCT03729609

Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"

The purpose of this survey is to monitor and identify the occurrence of neutropenia and febrile neutropenia in untreated CD30-positive Hodgkin's lymphoma partic…

Japan113 participantsStarted 2018-11-01

Treatment: Brentuximab vedotin (Genetical Recombination)